science
Podcast Discusses Biotech Summit and China Competition
The weekly biotech podcast covered conversations from a recent health care and science summit. Topics included research publication practices and the role of AI in drug development.
May 22, 4:33 PM·1m read1 source
ecns.cnAudio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.
The episode of the biotech podcast examined discussions from STAT's Breakthrough Summit West. Attendees included leaders from health care and science sectors. BridgeBio's chief executive commented that the company is publishing structures that are not the right ones in its research publications.
An interview featured the chief executive of Retro Biosciences, a company backed by Sam Altman. The firm is preparing its first clinical data readout and is assessing how artificial intelligence may affect drug development. The hosts also discussed reporting on how competition from China is affecting the biotech sector and the approach of one self-appointed spokesperson.
Transparency
How sources framed this
Single source — no framing comparison available.
CorroborationModerate · 1 source
